These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 23703776)
1. Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents. Huang RC; Beilin LJ; Ayonrinde O; Mori TA; Olynyk JK; Burrows S; Hands B; Adams LA Hepatology; 2013 Oct; 58(4):1306-14. PubMed ID: 23703776 [TBL] [Abstract][Full Text] [Related]
2. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659 [TBL] [Abstract][Full Text] [Related]
3. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity. Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084 [TBL] [Abstract][Full Text] [Related]
4. Sex dimorphism in the relation between early adiposity and cardiometabolic risk in adolescents. Huang RC; Mori TA; Burrows S; Le Ha C; Oddy WH; Herbison C; Hands BH; Beilin LJ J Clin Endocrinol Metab; 2012 Jun; 97(6):E1014-22. PubMed ID: 22442267 [TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome may be associated with increased arterial stiffness even in the absence of hypertension: a study in 84 cases and 82 controls. Kangas P; Tikkakoski AJ; Tahvanainen AM; Leskinen MH; Viitala JM; Kähönen M; Kööbi T; Niemelä OJ; Mustonen JT; Pörsti IH Metabolism; 2013 Aug; 62(8):1114-22. PubMed ID: 23557592 [TBL] [Abstract][Full Text] [Related]
6. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Manco M; Bedogni G; Marcellini M; Devito R; Ciampalini P; Sartorelli MR; Comparcola D; Piemonte F; Nobili V Gut; 2008 Sep; 57(9):1283-7. PubMed ID: 18218674 [TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease. Chan DT; Watts GF; Irish AB; Ooi EM; Dogra GK Am J Hypertens; 2013 Sep; 26(9):1155-61. PubMed ID: 23736110 [TBL] [Abstract][Full Text] [Related]
8. Dietary patterns and markers for the metabolic syndrome in Australian adolescents. Ambrosini GL; Huang RC; Mori TA; Hands BP; O'Sullivan TA; de Klerk NH; Beilin LJ; Oddy WH Nutr Metab Cardiovasc Dis; 2010 May; 20(4):274-83. PubMed ID: 19748245 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the cardiometabolic profiles of adolescents conceived through ART with those of a non-ART cohort. Wijs LA; Doherty DA; Keelan JA; Burton P; Yovich JL; Beilin L; Mori TA; Huang RC; Adams LA; Olynyk JK; Ayonrinde OT; Penova-Veselinovic B; Hart RJ Hum Reprod; 2022 Jul; 37(8):1880-1895. PubMed ID: 35640037 [TBL] [Abstract][Full Text] [Related]
10. The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals. Kim BJ; Kim NH; Kim BS; Kang JH Cardiology; 2012; 123(1):54-61. PubMed ID: 22986520 [TBL] [Abstract][Full Text] [Related]
11. Effects of increased systemic inflammation and central obesity on arterial stiffness in patients with nonalcoholic fatty liver disease. Chen JY; Chou CH; Tsai WC; Wang MC; Ho CS; Li YH; Tsai YS; Tsai LM J Am Soc Hypertens; 2012; 6(4):253-60. PubMed ID: 22651911 [TBL] [Abstract][Full Text] [Related]
15. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). Mager DR; Iñiguez IR; Gilmour S; Yap J JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771 [TBL] [Abstract][Full Text] [Related]
16. Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease. Omelchenko E; Gavish D; Shargorodsky M J Am Soc Hypertens; 2014 Jun; 8(6):376-80. PubMed ID: 24794207 [TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors. Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884 [TBL] [Abstract][Full Text] [Related]
18. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015 [TBL] [Abstract][Full Text] [Related]